Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.54 - $11.49 $1.06 Million - $2.21 Million
-192,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$11.35 - $13.7 $1.77 Million - $2.14 Million
-156,000 Reduced 44.83%
192,000 $2.23 Million
Q3 2021

Nov 15, 2021

BUY
$12.2 - $15.93 $1.02 Million - $1.34 Million
84,000 Added 31.82%
348,000 $4.75 Million
Q2 2021

Aug 16, 2021

BUY
$11.7 - $16.11 $163,800 - $225,540
14,000 Added 5.6%
264,000 $4.25 Million
Q1 2021

May 17, 2021

SELL
$12.84 - $17.26 $77,040 - $103,560
-6,000 Reduced 2.34%
250,000 $3.73 Million
Q4 2020

Feb 16, 2021

BUY
$14.61 - $17.59 $1.4 Million - $1.69 Million
96,000 Added 60.0%
256,000 $3.85 Million
Q3 2020

Nov 16, 2020

BUY
$11.64 - $16.86 $1.86 Million - $2.7 Million
160,000 New
160,000 $2.65 Million

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $57.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.